Found: 5
Select item for more details and to access through your institution.
Risk of major malformations in infants after first‐trimester exposure to benzodiazepines: Results from the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications.
- Published in:
- Depression & Anxiety (1091-4269), 2022, v. 39, n. 12, p. 751, doi. 10.1002/da.23280
- By:
- Publication type:
- Article
Barriers to care and treatment experiences among individuals with postpartum psychosis.
- Published in:
- Archives of Women's Mental Health, 2024, v. 27, n. 4, p. 637, doi. 10.1007/s00737-024-01447-z
- By:
- Publication type:
- Article
Pregnancy outcomes after first-trimester exposure to buspirone: prospective longitudinal outcomes from the MGH National Pregnancy Registry for Psychiatric Medications.
- Published in:
- Archives of Women's Mental Health, 2022, v. 25, n. 5, p. 923, doi. 10.1007/s00737-022-01250-8
- By:
- Publication type:
- Article
Breastfeeding practices among women taking second-generation antipsychotics: findings from the National Pregnancy Registry for Atypical Antipsychotics.
- Published in:
- Archives of Women's Mental Health, 2022, v. 25, n. 2, p. 511, doi. 10.1007/s00737-021-01162-z
- By:
- Publication type:
- Article
Reproductive Safety of Lurasidone and Quetiapine: Update from the National Pregnancy Registry for Psychiatric Medications.
- Published in:
- Journal of Women's Health (15409996), 2023, v. 32, n. 4, p. 452, doi. 10.1089/jwh.2022.0310
- By:
- Publication type:
- Article